Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen replacement and cardiomyocyte protection.

Richard D Patten1, Richard H Karas

  • 1Molecular Cardiology Research Institute, Tufts-New England Medical Center, Boston, MA 02111, USA.

Trends in Cardiovascular Medicine
|March 21, 2006
PubMed
Summary

Estrogen, specifically 17beta-estradiol (E(2)), protects heart cells from damage and death after myocardial infarction. This hormone activates key survival pathways in cardiomyocytes, reducing infarct size and apoptosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Sarcoid Cardiomyopathy: A Multicenter Retrospective Cohort Study.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2025
Same author

Delaying reperfusion plus left ventricular unloading reduces infarct size: Sub-analysis of DTU-STEMI pilot study.

Cardiovascular revascularization medicine : including molecular interventions·2023
Same author

Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis.

Circulation·2022
Same author

Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility Study.

Circulation. Heart failure·2022
Same author

The mitochondrial regulator PGC1α is induced by cGMP-PKG signaling and mediates the protective effects of phosphodiesterase 5 inhibition in heart failure.

FEBS letters·2021
Same author

MLK3 mediates impact of PKG1α on cardiac function and controls blood pressure through separate mechanisms.

JCI insight·2021

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Estrogen's vascular effects are well-documented, but its impact on myocardial function and cardiomyocyte biology remains less understood.
  • Myocardial infarction (MI) leads to significant cardiomyocyte death and adverse cardiac remodeling.
  • Understanding sex hormone effects on the heart is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the protective effects of estrogen on cardiomyocyte survival and cardiac remodeling following myocardial infarction.
  • To elucidate the molecular mechanisms underlying estrogen's cardioprotective actions in vivo and in vitro.
  • To determine estrogen's role in mitigating apoptosis induced by cardiotoxic agents.

Main Methods:

  • Ovariectomized female mice underwent permanent coronary ligation to induce myocardial infarction.

Related Experiment Videos

  • Physiological replacement with 17beta-estradiol (E(2)) was administered.
  • Western blotting and cell culture experiments were used to assess Akt signaling pathway activation.
  • Anthracycline-induced apoptosis in cultured cardiomyocytes was evaluated.

    • Main Results:

    • Physiological E(2) replacement significantly reduced infarct size and cardiomyocyte apoptosis at 24 and 72 hours post-MI.
    • In vivo, E(2) rapidly activated the Akt signaling pathway in the myocardium.
    • In vitro, E(2) activated Akt via estrogen receptor alpha (ERalpha) and phosphoinositide-3 (PI3)-kinase-dependent pathways.
    • Estrogen mitigated anthracycline-induced apoptosis in vitro through ER- and PI3-kinase-Akt-dependent mechanisms.

    Conclusions:

    • Estrogen exerts favorable effects on cardiomyocyte survival in both in vivo and in vitro models.
    • The Akt signaling pathway, mediated by ERalpha and PI3-kinase, is a key mechanism for estrogen's cardioprotection.
    • These findings highlight estrogen's potential therapeutic role in managing myocardial infarction and related cardiac conditions.